Lexeo Therapeutics (LXEO) Reiterated at Overweight by Cantor Fitzgerald Jan 13, 2026 07:08AM
Lexeo Therapeutics' (LXEO) PKP2-ACM Program Under the Radar - Cantor Fitzgerald Dec 10, 2025 07:31AM
Lexeo Therapeutics (LXEO) PKP2-ACM Data Can Put Stock on Radars - Cantor Fitzgerald Dec 1, 2025 06:58AM
Cantor Fitzgerald Starts Lexeo Therapeutics (LXEO) at Overweight Nov 20, 2025 06:06AM
Lexeo Therapeutics closes $153.8 million public offering and private placement Oct 20, 2025 04:05PM


Oct 20, 2025 04:05PM Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
Oct 16, 2025 11:30PM Lexeo Therapeutics prices $135 million public offering at $8 per share
Oct 16, 2025 11:29PM Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
Oct 16, 2025 04:32PM Lexeo Therapeutics launches stock offering and private placement
Oct 16, 2025 04:32PM Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants